论文部分内容阅读
目的:综合评价2014年湖北省晚期血吸虫病(以下简称晚血)核查与救治项目的绩效情况。方法:采用卫生经济学、流行病学、卫生统计学等领域相关研究方法对湖北省12个市晚血核查与救治的经费使用情况、临床路径实施、病人转归情况、人均核查与治疗费用、成本-效益情况进行评价。结果:2014年湖北省晚血核查项目资金使用率为100.00%,实际人均核查费用为58.98元/人次;晚血救治经费资金使用率为102.80%,人均救治费用为6 334元/人次,晚血危重病人人均治疗费用为7 932元,手术病人人均治疗费用为10 797元,新增病人人均治疗费用4 812元。晚血项目成本-效益比为2.59,晚血项目总效益为77 176 682.80元,省投资到位资金为14 895 695.50元。效益费用比为5.18,净效益为62 280 987.30元,净效益费用比为4.18。结论:2014年湖北省晚血核查与救治项目具有良好的经济效益和社会效益。
OBJECTIVE: To comprehensively evaluate the performance of 2014 check and treatment of advanced schistosomiasis in Hubei Province (hereinafter referred to as late blood). Methods: Using the related research methods of health economics, epidemiology and health statistics, the paper analyzed the use of funds, implementation of clinical pathology, patient turnover, per capita verification and treatment costs of late blood checkup and treatment in 12 cities of Hubei Province, Cost-benefit situation evaluation. Results: The fund utilization rate of late-blood check-up project in Hubei Province in 2014 was 100.00%, and the actual per-capita verification cost was 58.98 yuan / person; the utilization rate of late-blood rescue funds was 102.80%, the average per capita treatment cost was 6 334 yuan / person, The per capita treatment cost of critically ill patients was 7 932 yuan, the per capita treatment cost of surgical patients was 10 797 yuan, and the per capita treatment cost of new patients was 4 812 yuan. The cost-benefit ratio of late blood project is 2.59, the total benefit of late blood project is 77,176,882.80 yuan, and the capital investment in place is 14,895,695.50 yuan. Benefit cost ratio of 5.18, net benefit of 62 280 987.30 yuan, the net benefit cost ratio of 4.18. Conclusion: The project of late blood check and rescue in Hubei Province in 2014 has good economic and social benefits.